PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ALTO vs. PFE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ALTO and PFE is 0.12, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

ALTO vs. PFE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Alto Ingredients, Inc. (ALTO) and Pfizer Inc. (PFE). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%30.00%SeptemberOctoberNovemberDecember2025
9.39%
-10.03%
ALTO
PFE

Key characteristics

Sharpe Ratio

ALTO:

-0.23

PFE:

0.18

Sortino Ratio

ALTO:

0.14

PFE:

0.45

Omega Ratio

ALTO:

1.02

PFE:

1.05

Calmar Ratio

ALTO:

-0.16

PFE:

0.08

Martin Ratio

ALTO:

-0.54

PFE:

0.48

Ulcer Index

ALTO:

28.70%

PFE:

9.01%

Daily Std Dev

ALTO:

66.17%

PFE:

23.34%

Max Drawdown

ALTO:

-99.99%

PFE:

-54.82%

Current Drawdown

ALTO:

-99.96%

PFE:

-49.59%

Fundamentals

Market Cap

ALTO:

$125.70M

PFE:

$152.22B

EPS

ALTO:

-$0.51

PFE:

$0.75

Total Revenue (TTM)

ALTO:

$728.91M

PFE:

$45.86B

Gross Profit (TTM)

ALTO:

$11.59M

PFE:

$29.87B

EBITDA (TTM)

ALTO:

$5.76M

PFE:

$15.61B

Returns By Period

In the year-to-date period, ALTO achieves a 4.49% return, which is significantly higher than PFE's 1.62% return. Over the past 10 years, ALTO has underperformed PFE with an annualized return of -16.19%, while PFE has yielded a comparatively higher 2.81% annualized return.


ALTO

YTD

4.49%

1M

4.49%

6M

9.40%

1Y

-13.76%

5Y*

20.28%

10Y*

-16.19%

PFE

YTD

1.62%

1M

1.62%

6M

-10.03%

1Y

3.27%

5Y*

-1.30%

10Y*

2.81%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ALTO vs. PFE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ALTO
The Risk-Adjusted Performance Rank of ALTO is 3636
Overall Rank
The Sharpe Ratio Rank of ALTO is 3434
Sharpe Ratio Rank
The Sortino Ratio Rank of ALTO is 3636
Sortino Ratio Rank
The Omega Ratio Rank of ALTO is 3737
Omega Ratio Rank
The Calmar Ratio Rank of ALTO is 3737
Calmar Ratio Rank
The Martin Ratio Rank of ALTO is 3535
Martin Ratio Rank

PFE
The Risk-Adjusted Performance Rank of PFE is 4949
Overall Rank
The Sharpe Ratio Rank of PFE is 5454
Sharpe Ratio Rank
The Sortino Ratio Rank of PFE is 4545
Sortino Ratio Rank
The Omega Ratio Rank of PFE is 4343
Omega Ratio Rank
The Calmar Ratio Rank of PFE is 5151
Calmar Ratio Rank
The Martin Ratio Rank of PFE is 5353
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ALTO vs. PFE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Alto Ingredients, Inc. (ALTO) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ALTO, currently valued at -0.23, compared to the broader market-2.000.002.00-0.230.18
The chart of Sortino ratio for ALTO, currently valued at 0.14, compared to the broader market-4.00-2.000.002.004.000.140.45
The chart of Omega ratio for ALTO, currently valued at 1.02, compared to the broader market0.501.001.502.001.021.05
The chart of Calmar ratio for ALTO, currently valued at -0.16, compared to the broader market0.002.004.006.00-0.160.08
The chart of Martin ratio for ALTO, currently valued at -0.54, compared to the broader market0.0010.0020.00-0.540.48
ALTO
PFE

The current ALTO Sharpe Ratio is -0.23, which is lower than the PFE Sharpe Ratio of 0.18. The chart below compares the historical Sharpe Ratios of ALTO and PFE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.80-0.60-0.40-0.200.000.20SeptemberOctoberNovemberDecember2025
-0.23
0.18
ALTO
PFE

Dividends

ALTO vs. PFE - Dividend Comparison

ALTO has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 6.37%.


TTM20242023202220212020201920182017201620152014
ALTO
Alto Ingredients, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PFE
Pfizer Inc.
6.37%6.33%5.70%3.12%2.64%3.91%3.68%3.12%3.54%3.70%3.48%3.34%

Drawdowns

ALTO vs. PFE - Drawdown Comparison

The maximum ALTO drawdown since its inception was -99.99%, which is greater than PFE's maximum drawdown of -54.82%. Use the drawdown chart below to compare losses from any high point for ALTO and PFE. For additional features, visit the drawdowns tool.


-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%SeptemberOctoberNovemberDecember2025
-93.07%
-49.59%
ALTO
PFE

Volatility

ALTO vs. PFE - Volatility Comparison

Alto Ingredients, Inc. (ALTO) has a higher volatility of 17.77% compared to Pfizer Inc. (PFE) at 5.62%. This indicates that ALTO's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%SeptemberOctoberNovemberDecember2025
17.77%
5.62%
ALTO
PFE

Financials

ALTO vs. PFE - Financials Comparison

This section allows you to compare key financial metrics between Alto Ingredients, Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab